- Home
- WTBA vs ZURA Comparison
WTBA vs ZURA Comparison
Compare WTBA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | ZURA |
|---|---|---|
| Founded | 1893 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 455.4M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WTBA | ZURA |
|---|---|---|
| Price | $29.37 | $5.21 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $24.00 | $13.00 |
| AVG Volume (30 Days) | 52.0K | ★ 1.6M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | $22.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.03 | $1.88 |
| 52 Week High | $30.33 | $7.25 |
Technical Indicators
Market Signals| Indicator | WTBA | ZURA |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 44.02 |
| Support Level | $27.54 | $5.22 |
| Resistance Level | $30.33 | $5.87 |
| Average True Range (ATR) | 0.53 | 0.43 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 80.83 | 3.54 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.